GLP-3s & Weight Loss Medications: FAQs

Welcome to Episode 1, Part 2 of DC Dermatology Skin Truths with Dr. Lanny Dinh, featuring special guest Dr. Lindsey VanDyke. In this episode, we answer the most common patient questions about GLP-1 medications and the next generation of therapies, including emerging GLP-3 treatments. As medications like Semaglutide and Tirzepatide continue to transform weight management and metabolic health, patients are seeking clear, evidence-based information about benefits, risks, side effects, and long-term expectations. Dr. Dinh and Dr.Vandyke discuss what patients need to know before starting treatment, how these medications work, and what may be coming next in the rapidly evolving field of weight loss medicine. For more information or to schedule a consultation with Dr. Dinh, visit www.dinhdermatology.com or call (657)204- 9510. IG: @dcdermatology Dr. Lindsey Vandyke is dual board certified in Endocrinology and Internal Medicine, practicing in the DFW metroplex in Texas. To schedule a consultation via in person or telehealth, visit https://aidendo.com/ For more information: linktr.ee/drvandykedo This episode can also be found on Spotify for your convenience. DC Dermatology Skin Truths Ep. 1, Pt. 2: GLP-3s & Weight Loss Medications: FAQs #GLP1 #Semaglutide #Tirzepatide #WeightLoss #Dermatology #HealthcarePodcast #MetabolicHealth #MedicalPodcast #GLP3